relapsed or refractory Hodgkins lymphoma

EHA: ADC preps filings for Hodgkin lymphoma drug after ph2 readout
Pharmaforum
Mon, 06/13/22 - 10:46 am
ADC Therapeutics
antibody-drug conjugate
camidanlumab tesirine
EMA
relapsed or refractory Hodgkins lymphoma
Bristol-Myers receives positive CHMP opinion for Opdivo
Reuters
Fri, 10/14/16 - 11:50 am
Bristol-Myers Squibb
Opdivo
CHMP
relapsed or refractory Hodgkins lymphoma